RenovoRx, Inc. SEC filings RNXT
RenovoRx, Inc. has 292 filings in SEC EDGAR's recent list, going back to Apr 10, 2013. Its latest annual report, Form 10-K, was filed on Mar 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| RW | Filing | Oct 16, 2026 | — |
| EFFECT | Filing | Apr 27, 2026 | — |
| CORRESP | Letter to the SEC | Apr 23, 2026 | — |
| UPLOAD | Letter from the SEC | Apr 22, 2026 | — |
| D | Filing | Apr 9, 2026 | — |
| UPLOAD | Letter from the SEC | Aug 28, 2025 | — |
| CORRESP | Letter to the SEC | Aug 13, 2025 | — |
| UPLOAD | Letter from the SEC | Jul 29, 2025 | — |
| CORRESP | Letter to the SEC | Jul 18, 2025 | — |
| UPLOAD | Letter from the SEC | Jul 10, 2025 | — |
| NT 10-K | Filing | Mar 31, 2025 | Dec 31, 2024 |
| EFFECT | Filing | May 10, 2024 | — |
| EFFECT | Filing | May 10, 2024 | — |
| CORRESP | Letter to the SEC | May 8, 2024 | — |
| CORRESP | Letter to the SEC | May 8, 2024 | — |
| UPLOAD | Letter from the SEC | May 1, 2024 | — |
| UPLOAD | Letter from the SEC | Apr 24, 2024 | — |
| D | Filing | Apr 22, 2024 | — |
| D | Filing | Feb 9, 2024 | — |
| NT 10-Q | Filing | Aug 15, 2023 | Jun 30, 2023 |
| EFFECT | Filing | May 19, 2023 | — |
| CORRESP | Letter to the SEC | May 17, 2023 | — |
| UPLOAD | Letter from the SEC | May 16, 2023 | — |
| EFFECT | Filing | Nov 21, 2022 | — |
| EFFECT | Filing | Nov 21, 2022 | — |
| CORRESP | Letter to the SEC | Nov 18, 2022 | — |
| CORRESP | Letter to the SEC | Nov 18, 2022 | — |
| UPLOAD | Letter from the SEC | Nov 16, 2022 | — |
| UPLOAD | Letter from the SEC | Nov 16, 2022 | — |
| EFFECT | Filing | Aug 25, 2021 | — |
| CORRESP | Letter to the SEC | Aug 25, 2021 | — |
| CORRESP | Letter to the SEC | Aug 25, 2021 | — |
| CORRESP | Letter to the SEC | Aug 24, 2021 | — |
| CERT | Filing | Aug 24, 2021 | — |
| CORRESP | Letter to the SEC | Aug 20, 2021 | — |
| CORRESP | Letter to the SEC | Aug 20, 2021 | — |
| CORRESP | Letter to the SEC | Aug 12, 2021 | — |
| 8-A12B | Filing | Aug 11, 2021 | — |
| CORRESP | Letter to the SEC | Aug 10, 2021 | — |
| CORRESP | Letter to the SEC | Aug 10, 2021 | — |
| CORRESP | Letter to the SEC | Aug 5, 2021 | — |
| UPLOAD | Letter from the SEC | Jul 29, 2021 | — |
| DRSLTR | Filing | Jun 15, 2021 | — |
| DRS/A | Filing | Jun 15, 2021 | — |
| UPLOAD | Letter from the SEC | May 28, 2021 | — |
| DRSLTR | Filing | May 12, 2021 | — |
| DRS/A | Filing | May 12, 2021 | — |
| UPLOAD | Letter from the SEC | May 3, 2021 | — |
| DRS | Filing | Apr 2, 2021 | — |
| D | Filing | Jun 19, 2018 | — |
| D | Filing | Jan 5, 2016 | — |
| D | Filing | Dec 23, 2013 | — |
| D | Filing | Apr 10, 2013 | — |
Showing 53 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- RNXT (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Mountain View, CA
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1574094
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.